title: [New antioxidants as neuroprotective agents for the treatment of ischemic brain injury and neurodegenerative diseases].
abstract: Central nervous system disorders are the leading cause of mortality and disability in the world. Unfortunately, the possibility of pathogenetic therapy is limited and it is important to search for new drugs with neuroprotective mechanism of action. One of the most promising groups of drugs are antioxidants--substances that can neutralize free radicals and reduce oxidative stress. This review focuses on preclinical and clinical studies of new antioxidants.
authors: M A
authors: MA
authors: Belousova
authors: E A
authors: EA
authors: Korsakova
authors: E A
authors: EA
authors: Gorodetskaia
authors: E I
authors: EI
authors: Kalenikova
authors: O S
authors: OS
authors: Medvedev
mesh_terms: D000975:Antioxidants / Q000138:chemical synthesis / Q000145:classification / Q000494:pharmacology*; D002545:Brain Ischemia / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D005609:Free Radicals / Q000037:antagonists & inhibitors / Q000378:metabolism; D006801:Humans; D019636:Neurodegenerative Diseases / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D018696:Neuroprotective Agents / Q000138:chemical synthesis / Q000145:classification / Q000494:pharmacology*; D018384:Oxidative Stress / Q000187:drug effects
chemical_list: D000975:Antioxidants; D005609:Free Radicals; D018696:Neuroprotective Agents